rs61752103
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000286.3(PEX12):c.538C>T(p.Arg180*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R180R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000286.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 3A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P
- peroxisome biogenesis disorder type 3BInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PEX12 | ENST00000225873.9 | c.538C>T | p.Arg180* | stop_gained | Exon 2 of 3 | 1 | NM_000286.3 | ENSP00000225873.3 | ||
| PEX12 | ENST00000586663.2 | n.538C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 1 | ENSP00000466894.2 | ||||
| PEX12 | ENST00000585380.1 | c.538C>T | p.Arg180* | stop_gained | Exon 3 of 3 | 4 | ENSP00000466280.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152060Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251490 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74264 show subpopulations
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder 3A (Zellweger) Pathogenic:3
- -
- -
This sequence change creates a premature translational stop signal (p.Arg180*) in the PEX12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX12 are known to be pathogenic (PMID: 9090384, 9632816, 21031596). This variant is present in population databases (rs61752103, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of Zellweger syndrome (PMID: 9792857, 24627108). ClinVar contains an entry for this variant (Variation ID: 7774). For these reasons, this variant has been classified as Pathogenic. -
Peroxisome biogenesis disorder type 3B;C3553929:Peroxisome biogenesis disorder 3A (Zellweger) Pathogenic:2
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Peroxisome biogenesis disorder Pathogenic:1
Variant summary: PEX12 c.538C>T (p.Arg180X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 3.6e-05 in 251490 control chromosomes (gnomAD). c.538C>T has been reported in the literature in individuals affected with Zellweger Syndrome (Okumoto_1998, Chang_1998, Schabhuttl_2014, Gootjes_2004, Dranchak_2011). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Peroxisomal biogenesis disorder 3b Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at